Leap therapeutics reports fourth quarter and full year 2023 financial results

Cambridge, mass. , march 18, 2024 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended december 31, 2023.
LPTX Ratings Summary
LPTX Quant Ranking